DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 6Strides Pharma Science
03 1AVIV PHARMA
04 1Acella Pharmaceuticals
05 13Actavis Inc
06 1Aeon Formulations Private Limited
07 4Ajanta Pharma Limited
08 11Alembic Pharmaceuticals Limited
09 5Amneal Pharmaceuticals
10 1Anwita Drugs
11 4Apotex Inc
12 1Aurobindo Pharma Limited
13 7Avet Pharmaceuticals
14 2Bausch & Lomb Incorporated
15 2Bionpharma
16 2Changzhou Pharmaceutical Factory
17 9Chartwell Pharmaceuticals llc
18 1DenMat Dental
19 1Endo International
20 5Epic Pharma. LLC.
21 2Fresenius Kabi USA
22 1GALDERMA LABS LP
23 1GLAND PHARMA LIMITED
24 1Galderma
25 2HALSEY
26 3HEATHER
27 8Hikma Pharmaceuticals
28 1Holden Medical Laboratories Pvt. Ltd
29 2Impax Laboratories
30 3Interpharm
31 2JAMP PHARMA
32 1Kindos Pharmaceuticals
33 1LABORATOIRE RIVA INC.
34 1LARKEN LABS
35 11Lupin Ltd
36 1MANTRA PHARMA INC
37 2MS Pharma
38 10Mayne Pharma
39 3Mutual Pharmaceutical Company, Inc.
40 1Neopharma
41 2Nesher Pharmaceuticals USA LLC
42 1Novel Laboratories, Inc.
43 1Oryza Pharmaceuticals
44 1PRO DOC LIMITEE
45 2PVT FORM
46 1Pantex Holland
47 2Par Pharmaceutical
48 4Pelcoat Formulations
49 5Pfizer Inc
50 1Pharmanovia A/S
51 1Pharmaris
52 3Pharmascience Inc.
53 1Pliva Hrvatska
54 1Praxgen
55 1Precision Dose
56 3Prinston
57 2Qilu Animal Health Products
58 2Quad Pharma
59 1RACHELLE
60 1Ratiopharm GmbH
61 7Rising Pharmaceuticals Inc
62 2SANIS HEALTH INC
63 3SUPERPHARM
64 2Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
65 2Slate Run Pharmaceuticals
66 6Sun Pharmaceutical Industries Limited
67 5Teva Pharmaceutical Industries
68 2Torrent Pharmaceuticals Limited
69 2Unichem Laboratories Limited
70 2V-Ensure
71 2Viatris
72 1Virjo Healthcare
73 4Warner Chilcott Company, LLC
74 2West-ward Pharmaceutical Corp
75 2Zhejiang Yongtai Technology
76 3Zydus Lifesciences
77 5Zydus Pharmaceuticals
01 9CAPSULE
02 1CAPSULE, COATED PELLETS;ORAL
03 5CAPSULE, DELAYED RELEASE;ORAL
04 53CAPSULE;ORAL
05 1CONCENTRATE FOR SOLUTION FOR INFUSION
06 5Capsule
07 1Capsule IP
08 4Enteric Coated Pellets
09 23INJECTABLE;INJECTION
10 1Inection
11 2Injectable; Injection
12 1Injection
13 1ORAL SUSPENSION
14 1Oral Solution/Suspension
15 1PELLET
16 2Powder
17 1SYSTEM, EXTENDED RELEASE;PERIODONTAL
18 9TABLET
19 42TABLET, DELAYED RELEASE;ORAL
20 57TABLET;ORAL
21 2Tablet
22 1WSP / Premix
23 1Water Soluble Powder
01 103DISCN
02 6Generic
03 2Prescription
04 79RX
05 34Blank
01 2ACTICLATE
02 1ACTICLATE CAP
03 1APO-DOXY CAP 100MG
04 1APO-DOXY TABS 100MG
05 1ATRIDOX
06 9DORYX
07 2DORYX MPC
08 1DOXIEONnn
09 1DOXY 100
10 1DOXY 200
11 3DOXY-LEMMON
12 1DOXYCHEL HYCLATE
13 1DOXYCIN TAB 100MG
14 7DOXYCYCLINE
15 1DOXYCYCLINE CAPSULES
16 148DOXYCYCLINE HYCLATE
17 1DOXYCYCLINE TABLETS
18 1DOXYTAB
19 3Doxycycline Hyclate
20 1Doxyferm
21 1Doxyline-100
22 1Doxyline-200
23 2Doxy®
24 1Gendox 10/5
25 1JAMP DOXYCYCLINE
26 1JAMP DOXYCYCLINE CAPSULES
27 1LYMEPAK
28 1M-DOXYCYCLINE
29 1Neocycline
30 2PERIOSTAT
31 3PMS-DOXYCYCLINE
32 1PRZ-DOXYCYCLINE
33 2TEVA-DOXYCYCLINE
34 1VIBRA-TABS
35 4VIBRAMYCIN
36 1Vibranord
37 13Blank
01 15Canada
02 4China
03 15India
04 2Jordan
05 1Netherlands
06 2Sweden
07 1U.A.E
08 184USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-04-07
Application Number : 62538
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ATRIDOX
Dosage Form : SYSTEM, EXTENDED RELEASE;PERIODONTAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-09-03
Application Number : 50751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-30
Application Number : 50744
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-02-02
Application Number : 50783
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-07-22
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2001-08-13
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRA-TABS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50533
Regulatory Info : DISCN
Registration Country : USA
